Sofar S.P.A.
Records under this name other than the patents Sofar S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,251,713 | Robotized Surgery System with Improved Control Formerly held In force · High confidence | In force | High confidence | |
| US 11,857,278 | Roboticized Surgery System with Improved Control Formerly held In force · High confidence | In force | High confidence | |
| US 11,224,489 | Robotized Surgery System with Improved Control Formerly held In force · High confidence | In force | High confidence | |
| US 9,360,934 | Robotized Surgery System with Improved Control Formerly held In force · High confidence | In force | High confidence | |
| US 10,555,956 | Chemoprevention of colorectal cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,839,634 | Use of a Composition Comprising Microorganisms to Increase the Intestinal Production of Butyric Acid, Folic Acid or Niacin And/Or Decrease the Intestinal Production of Succinic Acid Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,464,814 | Topical composition for use in the treatment of inflammatory bowel disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,400,124 | Use of probiotics for improving protein absorption Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,752,179 | Medical use of probiotics Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,201,729 | Process for Mesalazine Solid Formulations Formerly held In force · High confidence | In force | High confidence |